Page last updated: 2024-09-02

morpholinoanthracycline mx2 and kt 6149

morpholinoanthracycline mx2 has been researched along with kt 6149 in 1 studies

Compound Research Comparison

Studies (morpholinoanthracycline mx2)	Trials (morpholinoanthracycline mx2)	Recent Studies (post-2010) (morpholinoanthracycline mx2)	Studies (kt 6149)	Trials (kt 6149)	Recent Studies (post-2010) (kt 6149)
53	15	0	39	3	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bungo, M; Fujiwara, Y; Fukuda, M; Horichi, N; Minato, K; Nakagawa, K; Niimi, S; Ohe, Y; Saijo, N; Sasaki, Y	1

Other Studies

1 other study(ies) available for morpholinoanthracycline mx2 and kt 6149

Article	Year
In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines. Cancer research, 1989, Aug-01, Volume: 49, Issue:15 Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Menogaril; Mitomycins; Nogalamycin; Tumor Cells, Cultured	1989

Article

Year

In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.

Cancer research, 1989, Aug-01, Volume: 49, Issue:15

Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Menogaril; Mitomycins; Nogalamycin; Tumor Cells, Cultured

1989